 SOUTH SAN FRANCISCO, Calif., Sept. 06, 2022 GLOBE NEWSWIRE -- Senti Biosciences, Inc. Nasdaq: SNTI Senti Bio, a biotechnology company innovating next-generation cell and gene therapies using its proprietary gene circuit platform, today announced that co-founder and CEO, Tim Lu, CFO, Deb Knobelman and CMDO, Kanya Rajangam will participate in a Fireside Chat at the Morgan Stanley 20th Annual Global Healthcare Conference on Wednesday, September 14, 2022 at 4:05 p.m. ET. 